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The International Agency for Research on Cancer (IARC, 2010a)
has classified 107 agents, mixtures or exposure circumstances as
Group 1 (carcinogenic to humans), many of which are encountered
in occupational settings, for example, asbestos and cadmium. An
additional 58 agents, mixtures or exposure circumstances have
been classified as Group 2A (probably carcinogenic to humans).
Those with occupational significance include diesel fumes and
benzidine-based dyes (IARC, 2010a). Table 1 (adapted from
Siemiatycki et al, 2004) shows the most important occupational
exposures in these two categories.
A comprehensive analysis of occupational exposures, with
quantitative estimates of the cancers attributable to them, has
been carried out by Imperial College London and the Health and
Safety Laboratory on behalf of the Health & Safety Executive by
Rushton et al (2007). This analysis has been updated and extended,
based on mortality in Britain in 2005 and incidence in 2004
(Rushton et al, 2010). Here, we have applied the population-
attributable fractions (PAFs) for Great Britain, as estimated in this
paper, to the estimated cancer incidence in UK in 2010.
METHODS
The methodology used to estimate PAFs of each cancer is
described in the papers by Rushton et al (2007, 2010). The
carcinogenic agents or exposure circumstances identified for each
cancer were those classified by the IARC as Group 1 or 2A
carcinogens (IARC, 2010a). Estimation of PAFs requires data on
the relative risk of each exposure, and the prevalence in the general
population.
Risk estimates were obtained from key studies, meta-analyses or
pooled studies, taking into account quality, such as relevance to
Britain, sample size, extent of control for confounders, adequacy of
exposure assessment, and clarity of case definition. Where
possible, risk estimates that had been adjusted for important
non-occupational confounding factors, for example, smoking
status, were selected. In general, dose–response risk estimates
were not available from the epidemiological literature, nor were
proportions of those exposed at different levels of exposure over
time available for the working population of Britain. However,
where possible risk estimates were obtained for an overall ‘lower’
level and an overall ‘higher’ level of exposure to the agents of
concern.
With respect to the latency between exposure and the elevated
risk of cancer, a ‘relevant exposure period’ was defined. For solid
tumours a latency of 10–50 years was assumed; for haematopoietic
neoplasms it was 0–20 years.
The proportion of the population exposed to each carcino-
genic agent or occupation was obtained from the total number
of people employed and the numbers potentially exposed to the
carcinogens of interest in each relevant industry/occupation
within Britain. If the study from which the risk estimates were
obtained was population based, an estimate of the proportion of
the population exposed was derived directly from the study data. If
the risk estimate was obtained from an industry-based study,
national data sources, the CARcinogen EXposure (CAREX)
database, the UK Labour Force Survey (LFS) or Census of
Employment (CoE) was used to obtain the proportions exposed
to the carcinogens concerned in Britain. Adjustment factors were
applied to the data to take account of the change in numbers
employed and the employment turnover during the ‘relevant
exposure period’.
The studies from which risk estimates were taken were often
mortality studies only and PAFs derived from these were applied
to numbers of registrations. The PAFs published by Rushton et al
(2010) have been applied to the estimated numbers of cancers in
the UK in 2010, with the following exceptions:
  We exclude occupationally induced non-melanoma skin can-
cers, for the reasons stated in the introduction – primarily that
enumeration of such tumours is very far from complete (so that
including them among the total cancers attributable to different
exposures is misleading).
  PAFs due to occupational exposure to environmental tobacco
smoke are included with other tobacco-related cancers in
Chapter 2 (Parkin, 2011).
RESULTS
Table 2 shows the estimated number of new cancer cases in 2010
for 22 types of cancer, the PAFs (from Rushton et al, 2010) and the
estimated numbers of cases due to occupational exposures. The *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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women), representing 3.7% of all cancers (excluding non-
melanoma skin cancers). The most substantial numbers are lung
cancers (exposures due to asbestos, silica, diesel engine exhausts,
mineral oils), mesotheliomas (asbestos) and breast cancer, related
to shift work that involves circadian disruption (IARC, 2010b).
Table 1 Occupational exposures linked to cancer risk and industries in which exposures can occur
Type of exposure Industries with possibility for exposure
Aromatic amines Previously used as intermediates in manufacture of dyes and pigments, textiles, paints, plastics, paper, drugs and
pesticides, and as antioxidants in preparation of rubber for tyres and cables
Arsenic Mining, (copper) smelting, vineyard workers, pesticide production (arsenical pesticides)
Asbestos Shipbuilding, construction, mining and milling, by-product manufacture, insulating, sheet-metal workers, asbestos cement
industry
Benzene Production, solvents in the shoe production industry, chemical pharmaceutical and rubber industries, printing industry,
gasoline additive
Diesel Transportation workers/drivers, bus drivers, road maintenance, mechanics and garage workers, dock workers
Formaldehyde Production, pathologists, medical laboratory technicians, plastics, textile and plywood industry
Leather dust Boot and shoe manufacture and repair
Certain metal compounds (cadmium
and cadmium compounds, chromium
VI compounds, nickel compounds, iron
and steel founding, nickel sulphides and
oxides, beryllium)
Iron and steel founding; house painting and paper hanging; smelting, metal founding and welding; occupations that
involve manufacture of cadmium oxide, cadmium alloys and cadmium pigments; production of nickel-cadmium
batteries; recapture of zinc during zinc refining; chromate production; chromate pigment production; chromium plating;
mechanics and those working with iron and metal ware; plumping
Mineral oils Metal workers; printing industry
Polycyclic aromatic hydrocarbons Industries with exposure to soots, coal tars, coal-tar pitches, aluminium production (pitch volatiles); e.g. chimney
sweeps, coal gasification, coke production, coal-tar distillation, paving and roofing, smelting and metal founders, engine
and motor exhausts
Radon Workers in underground haematite mines
Silica Mining; stone quarrying; granite production; ceramic and pottery industries; steel production
UV radiation Outdoor occupations
Vinyl chloride Production of vinyl chloride and polyvinyl chloride; plastics, rubber and resins manufacturing; car interior workers;
furniture makers; transportation workers
Wood dust Furniture and cabinet-making and construction, logging and sawmill workers, pulp and paper and paperboard industry
Adapted from Siemiatycki et al (2004).
Table 2 Estimated fractions of cancer cases in UK, 2010, attributable to occupational exposures
Observed cases PAF
a (%) Excess attributable cases
Cancer site ICD-10 code Males Females Males Females Males Females
Nasopharynx C11 267 178 11 2.5 29 4.5
Oesophagus C15 5713 2819 3.3 1.1 189 31
Stomach C16 4467 2577 3 0.3 134 7.7
Liver C22 2270 1298 0.2 0.1 4.5 1.3
Pancreas C25 4084 4280 0.02 0.01 0.8 0.4
Sino-nasal
b C30–31 279 173 46 20.1 128 35
Larynx C32 1803 386 2.9 1.6 52 6.2
Lung
c C33 22273 18132 20.5 4.3 4566 780
Bone C40–41 362 256 0.04 0.01 0.1 0.0
Mesothelioma
b C45 2077 462 97 82.5 2015 381
Soft-tissue sarcoma
b C49 867 623 3.4 1.1 29 6.9
Breast (female) C50 — 48385 — 4.6 — 2226
Cervix C53 — 2691 — 0.7 — 19
Ovary C56 — 6820 — 0.5 — 34
Kidney C64–66, C68 5697 3365 0.04 0.04 2.3 1.3
Bladder C67 6713 2572 7.1 1.9 477 49
Eye
b C69 210 172 2.9 0.4 6.1 0.7
Brain and CNS C70–72 2799 1902 0.5 0.1 14 1.9
Thyroid C73 602 1776 0.12 0.02 0.7 0.4
Non-Hodgkin lymphoma C82–85, C96 6297 5305 2.1 1.1 132 58
Myeloma C90 2506 1994 0.4 0.1 10 2.0
Leukaemia C91–95 4639 3201 0.9 0.5 42 16
All
d 158667 155584 4.9 2.4 7832 3662
Abbreviations: CNS¼central nervous system; ICD¼International Classification of Diseases; PAF, population-attributable fraction.
aRushton et al (2010).
bNumber of cases
estimated from the UK population (2010) and rates in England in 2008.
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Included in the evaluation of Rushton et al (2010) were
non-melanoma skin cancers, the calculated PAF of which (4. 6%)
was applied directly to the number of registrations in 2004. The
latter may have been due to a lack of appreciation by the authors of
the incomplete nature of cancer registration for non-melanoma
skin cancer. Undercounting of such cancers is a consequence of
the relatively trivial nature of the great majority, and many such
cancers are treated without hospitalization or, probably, a biopsy.
Registration is biased by cell type (basal cell cancers will certainly
be undercounted), while some cancers – probably occupationally
related ones – may be more completely identified.
Prevalence of exposure in the analysis by Rushton et al (2010)
was estimated for a period of 10–50 years prior to 2005 for solid
tumours, and 0–20 years for haematopoietic neoplasms. If
exposure prevalence has been declining, and these latency periods
are correct, it is possible that the numbers of attributable cancers
for 2010 will be slightly overestimated (because the time since
exposure is 5 years longer than for the estimates for 2005).
Several other studies have been carried out to estimate the
proportion of cancers in a given population that are possibly the
result of exposure to carcinogens in an occupational setting. Doll
and Peto (1981) included occupational factors in their evaluation
of the quantitative contribution of different factors to cancer
mortality in the United States. In addition to the USA, estimates of
the effect of occupational exposures on the burden of cancer have
been made for the year 2000 for the populations of the Nordic
countries (Dreyer et al, 1997), Australia (Fritschi and Driscoll,
2006) and France (IARC, 2007). Quantitative estimates of the
carcinogenic effect of 11 occupational exposures worldwide in the
year 2000 were made by Driscoll et al (2005).
These recent studies used a methodology similar to that of
Rushton et al (2010) – the CAREX (CARcinogen Exposure)
database – to provide national estimates of the proportions of
workers exposed to different carcinogens and their levels of
exposure (Finnish Institute of Occupational Health, 2009), and
estimates of the relative risk of different exposures, drawn from
literature reviews. There are differences not only in the choice of
such studies (and hence of risks associated with occupational
exposures, and different levels of exposure), but also in the precise
choice of exposures, which can reasonably be considered to be
carcinogenic in an occupational setting.
The Nordic study (Dreyer et al, 1997) estimated that verified
industrial carcinogens will account for approximately 3% of all
cancers in men and less than 0.1% of all cancers in women in the
Nordic countries around the year 2000, while the French study
estimated that 2.5% of cancers in men and 0.3% in women were
caused by occupation.
See acknowledgements on page Si.
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